C742T mutation of α1, 3 N-acetyl-D-galactosaminyltransferase gene is responsible for A2 subgroup.
- Author:
Xiao-Zhen HONG
1
;
Yan-Ling YIN
;
Xian-Guo XU
;
Kai-Rong MA
;
Xiao-Fei LAN
;
Ying LIU
;
Fa-Ming ZHU
;
Hang-Jun LÜ
;
Li-Xing YAN
Author Information
1. Institute of Blood Transfusion, Zhejiang Provincial Blood Center, Key Laboratory of Blood Safety Research of Health Ministry, Hangzhou 310006, Zhejiang Province, China.
- Publication Type:Journal Article
- MeSH:
ABO Blood-Group System;
genetics;
immunology;
Alleles;
Antibodies, Anti-Idiotypic;
immunology;
Blood Donors;
Exons;
Genotype;
Heterozygote;
Humans;
Molecular Sequence Data;
Mutation;
N-Acetylgalactosaminyltransferases;
genetics;
Phenotype;
Sequence Analysis, DNA
- From:
Journal of Experimental Hematology
2011;19(3):702-705
- CountryChina
- Language:Chinese
-
Abstract:
The objective of this study was to analyze the molecular genetic basis for 2 individuals with A2B phenotype of ABO subtype. The ABO group antigens on red blood cells were identified by monoclonal antibodies and the ABO antibodies in serum were detected by the standard A, B, O cells. The exon 5 to exon 7 coding region of ABO gene was amplified by polymerase chain reaction (PCR) and the PCR product was sequenced directly after the enzymes digested. The amplified product was also cloned by TOPO TA cloning sequencing kit to split the 2 alleles apart and chosen colonies were sequencing bidirectionally for exon 6 to 7 of ABO gene. The results showed that both A and B antigen were identified on red blood cells of the individuals and there was anti-A1 antibody in their serum. There was no 261G deletion and showed 297A/G, 467C/T, 526C/G, 657C/T, 703G/A, 742C/T, 796C/A, 803G/C, 930G/A heterozygotes by direct DNA sequencing. After cloning and sequencing, it was obtained the B101 and one novel A allele. The novel allele has one nucleotide change at 742 position C to T compared with A102, which results in an amino acid Arg to Cys at 248 position and was nominated as A213. It is concluded that C742T mutation of the α1, 3 N-acetyl-D-galactosaminyl-transferase gene can lead to A2 phenotype and with anti-A1 antibody in serum.
